Drug Safety in the Limelight

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-05-02-2003, Volume 27, Issue 5

FDA resolves the bar code labeling debate, releases its GMP requirements for dietary supplements, and proposes a comprehensive adverse-event reporting system.

Related Content:

Regulatory WatchPharmaceutical Technology-05-02-2003
Signing Off from Washington
Industry Challenges Medicare Price Negotiation Scheme
Drug Shortages Continue to Plague FDA and Manufacturers